Table 1.
Characteristics | Placebo (N=126) | Chemo (N=124) | p-value | |
---|---|---|---|---|
Age – median (min, max) | 63(40,81) | 61(37,78) | 0.2180 | |
Gender | Male | 84 (67%) | 77 (62%) | 0.4505 |
Female | 42 (33%) | 47 (38%) | ||
Race | White | 109 (87%) | 112 (91%) | 0.3296 |
Non-white | 16 (13%) | 11 (9%) | ||
Performance Status | Fully active | 71 (57%) | 68 (55%) | 0.7011 |
Others | 53 (43%) | 56 (45%) | ||
Weight loss in previous 6 months | < 5% | 96 (81%) | 92 (80%) | 0.7932 |
≥ 5% | 22 (19%) | 23 (20%) | ||
Symptoms | Presence | 96 (76%) | 99 (80%) | 0.4863 |
Absence | 30 (24%) | 25 (20%) | ||
Diagnosis | Squamous cell | 40 (32%) | 46 (37%) | 0.6440 |
Adenocarcinoma | 68 (54%) | 61 (50%) | ||
Other types | 18 (14%) | 16 (13%) | ||
Smoking History | Yes | 125 (99%) | 120 (97%) | 0.1696 |
No | 1 (1%) | 4 (3%) |
The p-value for age was from the t-test, while Chi-square tests were used for the categorical variables.